Baird’s Boston Scientific BSX Stock Holding History

Baird’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$689K	Buy	38,845 +2,225	+6%	+$35.2K	0.01%	857
2014 Q4	$485K	Buy	+36,620	New	+$468K	0.01%	958

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Baird's BSX Position: Q1 2015 in Review

Baird increased its Boston Scientific (BSX) stake by 6.1% in Q1 2015, buying an estimated $35.2K and bringing the position to 38,845 shares worth $689K. The position accounts for 0.01% of the portfolio, ranked #857.

Baird first reported a position in BSX in Q4 2014 and has held it in 2 quarters since. 469 funds tracked by Wall St. Rank hold BSX as of Q1 2015.

Baird held 38,845 shares of Boston Scientific worth $689K as of Q1 2015.
Baird bought 2,225 Boston Scientific shares in Q1 2015, an estimated $35.2K.
Boston Scientific made up 0.01% of Baird's portfolio in Q1 2015, its #857 holding.
Baird first reported a position in Boston Scientific in Q4 2014 and has held it in 2 quarters since.
469 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.